IBEC is bioprinting partner in major 3D printing hub in Catalonia Blog Post

The Institute for Bioengineering of Catalonia (IBEC), based at Barcelona Science Park, is to be part of a the Global 3D Printing Hub, a 3D printing infrastructure in Catalonia, which will receive up to 28 million euros from the Generalitat by 2020 to consolidate Catalonia as a world leader in 3D printing, one of the key technologies in industry 4.0. The Global 3D Printing Hub will be headquartered in 10.000m2 of the Campus Diagonal Besòs in Barcelona.

 

A genome-editing strategy to study cancer stem cells in human tumours Blog Post

In EMBO Molecular Medicine, IRB Barcelona scientists at PCB report a technique based on a combination of CRISPR/Cas9 genome editing and patient-derived tumour organoids that allows the study of cell heterogeneity in human tumours.The novel approach was used to examine the behaviour of colorectal cancer stem cells by tracing specific marker genes.

 

A study reveals the biological changes in breast cancer between the primary tumour and metastases Blog Post

Researchers at  the Institute for Research in Biomedicine (IRB Barcelona) and the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and have described that the longer the time from the onset of the tumour to the development of metastasis is, the more aggressive this cancer becomes. The work – published in Cancer Research– has also shown that between the initial tumour and the metastasis the subtype of breast cancer can change in up to 40% of cases.

 

Minoryx successfully completes phase 1 clinical trial for lead candidate MIN-102 Blog Post

Minoryx Therapeutics – a drug development company specialized in the discovery and development of new drugs for orphan diseases, which has R& D laboratories at the Barcelona Science Park– announces that it has successfully completed its phase 1 trial with its lead compound MIN-102 targeting X-linked adrenoleukodystrophy (X-ALD), a life threatening orphan CNS disease with high unmet medical need.

 

Samuel receives the Catalonian National Research Award for Young Talent Blog Post

Yesterday IBEC group leader and ICREA research professor Samuel Sánchez at PCB, received the Catalonian National Research Award for Young Talent from the Catalan Government and the Catalan Foundation for Research and Innovation (FCRI).This prestigious honour and cash prize of €10,000 aims to encourage and acknowledge young researchers whose work and research has stood out during their professional career.

 

The AECC supports cancer research at IRB Barcelona Blog Post

Today, Jelena Urosevic and Carles Barceló, postdoctoral fellows at the Institute for Research in Biomedicine (IRB Barcelona) at the Barcelona Science Park, will officially be presented with funding over 5 years from the Asociación Española Contra el Cáncer (AECC) for their respective research projects on colon cancer. To date, IRB Barcelona has secured AECC funding for eight cancer projects.

 

The FBG receives € 150,000 from the AECC for childhood cancer research Blog Post

The project on neuroblastoma led by Elisa Martí Gorostiza, researcher at the Institute of Molecular Biology of Barcelona (IBMB-CSIC), based at PCB, and the Catalan Biotechnology Reference Network (XRB), has received one of the three grants for research projects on childhood cancer funded by the Spanish Association Against Cancer (AECC). The € 150,000 grant, obtained with the collaboration of the XRB, will be managed by the Bosch i Gimpera Foundation (FBG).

 

CataloniaBio grants the ‘BioSuccess of the Year’ award to STAT-Diagnostica Blog Post

The Catalan Association of Biotechnology Companies (CataloniaBio) has recognized Stat-Diagnostica –founded in 2010 at the Barcelona Science Park by Jordi Carrera and Rafael Bru– with the ‘Biosuccess of the Year’ Award. The prize giving ceremony was held yesterday at the Museu Maritimo of Barcelona under his winter networking event CataloniaBio Gala Dinner, a yearly meeting organised by this business association with the aim of enhancing scientific-business cooperation in Catalonia in the field of life sciences and health.

 

Dr Thomas Högberg to head up Mind the Byte office in Scandinavia Blog Post

Mind the Byte, located at the Barcelona Science Park, continues to reinforce its international presence. To this end, Thomas Högberg is joining the company as Business Development Director Scandinavia and Senior Advisor in order to consolidate computational design services in one of the most important pharmaceutical and biotechnology markets in Europe. He will carry out these responsibilities from the company’s offices at the Copenhagen Bio Science Park (COBIS).

 

Researchers find a gene that causes Opitz C syndrome in the only patient diagnosed in Catalonia Blog Post

A team led by the professors Daniel Grinberg and Susana Balcells, from the Institute of Biomedicine of the University of Barcelona (IBUB) at the Barcelona Science Park has identified a gene that causes the Opitz C syndrome in the only patient in Catalonia diagnosed with this genetic disease  which, so far, does not offer treatment possibilities, prenatal diagnosis or genetic counseling. This new scientific advance is a first step to discover the genetic bases of this congenital disease, that causes severe disabilities in patients and has been diagnosed in three people in the Iberian Peninsula, and sixty people in the world.